hair loss; Headache; a red circle; Severe pain, at the injection site / throbbing; swelling at the injection site; Couldnt sleep d/t throbbing at site.; This spontaneous case was reported by a nurse and describes the occurrence of SLEEP DISORDER (Couldnt sleep d/t throbbing at site.), ALOPECIA (hair loss), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (a red circle) and VACCINATION SITE PAIN (Severe pain, at the injection site / throbbing) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided by the reporter.  The patient's past medical history included Solitary kidney (Has only L kidney, as R was removed d/t poss Cancer). Concurrent medical conditions included Drug allergy (Codeine). Concomitant products included CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) for Arthritis, ATORVASTATIN for Hypercholesterolemia, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) for Hypertension, PROBIOTICS NOS, CA [CALCIUM] and NICOTINAMIDE (VIT B3) for an unknown indication, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS).   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced SLEEP DISORDER (Couldnt sleep d/t throbbing at site.), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (a red circle), VACCINATION SITE PAIN (Severe pain, at the injection site / throbbing) and VACCINATION SITE SWELLING (swelling at the injection site). On an unknown date, the patient experienced ALOPECIA (hair loss). On 07-Feb-2021, VACCINATION SITE PAIN (Severe pain, at the injection site / throbbing) had resolved. On 11-Feb-2021, SLEEP DISORDER (Couldnt sleep d/t throbbing at site.), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (a red circle) and VACCINATION SITE SWELLING (swelling at the injection site) had resolved. At the time of the report, ALOPECIA (hair loss) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Dec-2020, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SLEEP DISORDER (Couldnt sleep d/t throbbing at site.), ALOPECIA (hair loss), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (a red circle) and VACCINATION SITE SWELLING (swelling at the injection site) to be possibly related. No further causality assessment was provided for VACCINATION SITE PAIN (Severe pain, at the injection site / throbbing).    Patient reports she was hospitalized  at Hospital 12/11-12/14 where she received 3 treatments of Remdesivir and steroids. Treatment for the event included acetaminophen (Tylenol) and Nutrasol for hair loss possibly related to the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: New event added, lab, concomitant medications, event outcome , causality and vaccine information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.